Analyst Recommendations
Jefferies analyst issues BUY recommendation for GSK on June 4, 2024 08:35AM ET. The previous analyst recommendation was Buy.GSK was trading at $40.88 at issue of the analyst...June 4, 2024 GSK 1.23%
Wells Fargo analyst issues EQUAL-WEIGHT recommendation for SR on June 4, 2024 08:04AM ET. The previous analyst recommendation was Equal-Weight.SR was trading at $61.31 at issue of the...June 4, 2024 SR -1.17%
B. Riley analyst issues BUY recommendation for CCIF on June 4, 2024 08:15AM ET. CCIF was trading at $8.37 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest 10...June 4, 2024 CCIF -5.81%
Rodman & Renshaw analyst issues BUY recommendation for ANVS on June 4, 2024 08:26AM ET. ANVS was trading at $6.81 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest...June 4, 2024 ANVS 29.76%
Lake Street analyst issues BUY recommendation for LUNG on June 4, 2024 08:09AM ET. LUNG was trading at $6.9 at issue of the analyst recommendation.The overall analyst consensus...June 4, 2024 LUNG -4.36%
Janney Montgomery analyst issues NEUTRAL recommendation for NWN on June 4, 2024 08:04AM ET. NWN was trading at $37.58 at issue of the analyst recommendation.The overall analyst consensus...June 4, 2024 NWN -0.46%
Wells Fargo analyst issues UNDERWEIGHT recommendation for ENB on June 4, 2024 06:34AM ET. The previous analyst recommendation was Underweight.ENB was trading at $36.43 at issue of the...June 4, 2024 ENB 0.20%
H.C. Wainwright analyst issues BUY recommendation for CRBU on June 4, 2024 06:46AM ET. The previous analyst recommendation was Buy.CRBU was trading at $2.145 at issue of the...June 4, 2024 CRBU -5.03%
Oppenheimer analyst issues OUTPERFORM recommendation for LVRO on June 4, 2024 06:41AM ET. The previous analyst recommendation was Outperform.LVRO was trading at $6.47 at issue of the analyst...June 4, 2024 LVRO 5.24%
Benchmark analyst issues BUY recommendation for SPOT on June 4, 2024 06:48AM ET. The previous analyst recommendation was Buy.SPOT was trading at $313.62 at issue of the analyst...June 4, 2024 SPOT 1.19%